Evidence map›Paper›PMID 37341483›Full record

ArticlemBio2023

Topology and function of translocated EspZ.

Nir Haritan, Etan Amse Bouman, Ipsita Nandi, Raisa Shtuhin-Rahav, Efrat Zlotkin-Rivkin, Tsafi Danieli, Naomi Melamed-Book, Yael Nir-Keren, Benjamin Aroeti

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nir Haritan *Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Etan Amse Bouman *Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Ipsita NandiDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Raisa Shtuhin-RahavDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Efrat Zlotkin-RivkinDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Tsafi DanieliThe Protein Production Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Naomi Melamed-BookBioimaging Unit, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Yael Nir-KerenThe Protein Production Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.
Benjamin AroetiDepartment of Biological Chemistry, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem , Jerusalem, Israel.ORCID 0000-0003-2023-7913
Hebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EspZ and Tir are essential virulence effectors of enteropathogenic

Indexed as

Escherichia coliCell AdhesionCell DeathCell Line, TumorEscherichia coli ProteinsHumansEscherichia coli ProteinsEspZ protein, E colibacterial colonizationcell deathenteropathogenic E. coliEspZhost–pathogen interactionsmitochondriaTirtype III secreted effectors

Identifiers

PMID37341483
PMCPMC10470495
OpenAlexW4381470652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.